Permanent phenotypic correction of Haemophilia B in immunocompetent mice by prenatal gene therapy

被引：0
|
作者：
Waddington, SN
Nivsarkar, M
Mistry, A
Buckley, SMK
Kemball-Cook, G
Mosley, KL
Mitrophanous, K
Radcliffe, P
Holder, M
Brittan, M
Georgiadis, T
Al-Allaf, F
Bigger, B
Gregory, L
Cook, HT
Ali, RR
Thrasher, A
Tuddenham, EGD
Themis, M
Coutelle, C
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Gene Therapy Res Grp, Sect Cell & Mol Biol, London SW7 2AZ, England
[2] Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England
[3] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England
[4] Univ London Imperial Coll Sci Technol & Med, Fac Med, Renal Med Sect, London W12 0NN, England
[5] Oxford BioMed UK Ltd, Oxford OX4 4GA, England
[6] Canc Res UK, Histopathol Unit, London WC2A 3PX, England
[7] UCL, Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England
来源：
JOURNAL OF GENE MEDICINE | 2004年 / 6卷 / 09期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
42
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [21] NICE recommends new gene therapy for adults with haemophilia B
    Iacobucci, Gareth
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 385
  • [22] Gene therapy trial in severe haemophilia B - interim results
    Tuddenham, E. G.
    HAEMOPHILIA, 2012, 18 : 10 - 10
  • [23] New genes for old: successful gene therapy for haemophilia B
    Roberts, D. J.
    TRANSFUSION MEDICINE, 2012, 22 (01) : 3 - 4
  • [24] Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy
    Connelly, S
    Andrews, JL
    Gallo, AM
    Kayda, DB
    Qian, JH
    Hoyer, L
    Kadan, MJ
    Gorziglia, MI
    Trapnell, BC
    McClelland, A
    Kaleko, M
    BLOOD, 1998, 91 (09) : 3273 - 3281
  • [25] COMBINATORIAL GENE THERAPY AND NO SUPPLEMENTATION FOR PHENOTYPIC CORRECTION OF ARGININOSUCCINIC ACIDURIA
    Shchelochkov, O. A.
    Erez, A.
    Brunetti-Pierri, N.
    Nagamani, S. C. S.
    Chen, Y.
    Palmer, D.
    Bryan, N. S.
    Lee, B.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 10 - 10
  • [26] Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
    A. Barzel
    N. K. Paulk
    Y. Shi
    Y. Huang
    K. Chu
    F. Zhang
    P. N. Valdmanis
    L. P. Spector
    M. H. Porteus
    K. M. Gaensler
    M. A. Kay
    Nature, 2015, 517 : 360 - 364
  • [27] Factor IX gene therapy expression in normal-weight vs. adipose haemophilia B mice
    Coulibaly, S.
    Weiller, M.
    Bauer, A.
    Lengler, J.
    Romeder-Finger, S.
    Kopic, A.
    Benamara, K.
    Monahan, P.
    Rottensteiner, H.
    Scheiflinger, F.
    Turecek, M.
    Hoellriegl, W.
    HUMAN GENE THERAPY, 2017, 28 (12) : A23 - A23
  • [28] Progressive improvement in wound healing with increased therapy in haemophilia B mice
    Monroe, D. M.
    Hoffman, M.
    Roberts, H. R.
    Hedner, U.
    HAEMOPHILIA, 2013, 19 (06) : 926 - 932
  • [29] Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX
    Bigger, BW
    Siapati, EK
    Mistry, A
    Waddington, SN
    Nivsarkar, MS
    Jacobs, L
    Perrett, R
    Holder, MV
    Ridler, C
    Kemball-Cook, G
    Ali, RR
    Forbes, SJ
    Coutelle, C
    Wright, N
    Alison, M
    Thrasher, AJ
    Bonnet, D
    Themis, M
    GENE THERAPY, 2006, 13 (02) : 117 - 126
  • [30] Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX
    B W Bigger
    E K Siapati
    A Mistry
    S N Waddington
    M S Nivsarkar
    L Jacobs
    R Perrett
    M V Holder
    C Ridler
    G Kemball-Cook
    R R Ali
    S J Forbes
    C Coutelle
    N Wright
    M Alison
    A J Thrasher
    D Bonnet
    M Themis
    Gene Therapy, 2006, 13 : 117 - 126
12345